Genetically Predicted Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease
- 1 October 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 210 (7) , 890-899
Abstract
Rationale: Body mass index (BMI) is associated with chronic obstructive pulmonary disease (COPD) mortality, but the underlying mechanisms are unclear. The effect of genetic variants aggregated into a polygenic score may elucidate the causal mechanisms and predict risk. Objectives: To examine the associations of genetically predicted BMI with all-cause and cause-specific mortality in COPD. Methods: We developed a polygenic score (PGS) for BMI (PGSBMI) and tested for associations of the PGSBMI with all-cause, respiratory, and cardiovascular mortality in participants with COPD from the COPDGene (Genetic Epidemiology of COPD), ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points), and Framingham Heart studies. We calculated the difference between measured BMI and PGS-predicted BMI (BMIdiff) and categorized participants into groups of discordantly low (BMIdiff 80th percentile) BMI. We applied Cox models, examined potential nonlinear associations of the PGSBMI and BMIdiff with mortality, and summarized results with meta-analysis. Measurements and Main Results: We observed significant nonlinear associations of measured BMI and BMIdiff, but not PGSBMI, with all-cause mortality. In meta-analyses, a one–standard deviation increase in the PGSBMI was associated with an increased hazard for cardiovascular mortality (hazard ratio [HR], 1.29; 95% confidence interval [CI], 1.12–1.49), but not for respiratory or all-cause mortality. Compared with participants with concordant measured and genetically predicted BMI, those with discordantly low BMI had higher risks for all-cause mortality (HR, 1.57; 95% CI, 1.41–1.74) and respiratory death (HR, 2.01; 95% CI, 1.61–2.51). Conclusions: In people with COPD, a higher genetically predicted BMI is associated with higher cardiovascular mortality but not respiratory mortality. Individuals with a discordantly low BMI have higher all-cause and respiratory mortality rates than those with a concordant BMI.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (K08HL159318)
- Alpha-1 Foundation
- National Heart, Lung, and Blood Institute (K08HL159318)
- Alpha-1 Foundation
This publication has 51 references indexed in Scilit:
- Genetically and environmentally predicted obesity in relation to cardiovascular disease: a nationwide cohort studyeClinicalMedicine, 2023
- Machine Learning and Prediction of All-Cause Mortality in COPDChest, 2020
- Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision PreventionCurrent Obesity Reports, 2020
- Clinical outcome and cost-effectiveness of a 1-year nutritional intervention programme in COPD patients with low muscle mass: The randomized controlled NUTRAIN trialClinical Nutrition, 2020
- Polygenic Prediction of Weight and Obesity Trajectories from Birth to AdulthoodCell, 2019
- BMI and Mortality in UK Biobank: Revised Estimates Using Mendelian RandomizationObesity, 2018
- Multiethnic polygenic risk scores improve risk prediction in diverse populationsGenetic Epidemiology, 2017
- Targeted medical nutrition for cachexia in chronic obstructive pulmonary disease: a randomized, controlled trialJournal of Cachexia, Sarcopenia and Muscle, 2017
- Polygenic scores via penalized regression on summary statisticsGenetic Epidemiology, 2017
- Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspectiveJournal of Cachexia, Sarcopenia and Muscle, 2015